Diagnostics / pathology

Metabolic syndrome may leave a signature in mitochondrial DNA. The biomarker race should not outrun the evidence

Breast Cancer Gets a New PI3K Pathway Option.

A Blood Test Will Not Fix Colorectal Screening by Itself

Gonorrhoea Is Learning To Beat Ceftriaxone. Europe Must Move First.

Early Lung Cancer Just Became a Biomarker Test of the System

Pancreatic Cancer’s ADC Moment Will Live or Die by the Biomarker

KRAS Has a New Contender. It Still Has to Earn Its Place.

Cyclospora Is Spreading. The Food Chain Still Has No Answer.

China’s Biliary-Cancer Bet Has a Global Access Problem
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
